 INTRAVENOUS AND INTRAPERITONEAL PACLITAXEL, INTRAPERITONEAL CISPLATIN, AND INTRAVENOUS BEVACIZUMAB FOR THE INITIAL TREATMENT OF OPTIMAL STAGE II OR III OVARIAN, PRIMARY PERITONEAL, AND FALLOPIAN TUBE CANCER: 